TrxR1 Antibodies

Santa Cruz Biotechnology features a diverse variety of TrxR1 monoclonal antibodies for investigating thioredoxin reductase 1 (TrxR1) in cellular processes. TrxR1 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). TrxR1 is a crucial enzyme that maintains cellular redox balance and protects cells from oxidative stress. The enzyme regulates the thioredoxin system, which is essential for various biological processes, including cell proliferation, apoptosis, and immune response. TrxR1's significant role in cancer biology has established it as a promising therapeutic target. Researchers can utilize TrxR1 monoclonal antibodies to examine protein expression patterns across different cell types and tissues. Advanced research techniques incorporating TrxR1 monoclonal antibodies enable detailed analysis of protein-protein interactions and cellular localization. Understanding TrxR1's role in disease progression and therapeutic development continues to be an active area of scientific investigation. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of cellular processes and potential therapeutic applications.